Ali Tehrani - Net Worth and Insider Trading

Ali Tehrani Net Worth

The estimated net worth of Ali Tehrani is at least $5 Million dollars as of 2024-11-09. Ali Tehrani is the CEO of Zymeworks Inc and owns about 315,836 shares of Zymeworks Inc (ZYME) stock worth over $5 Million. Details can be seen in Ali Tehrani's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ali Tehrani has not made any transactions after 2021-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ali Tehrani

To

Ali Tehrani Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ali Tehrani owns 1 companies in total, including Zymeworks Inc (ZYME) .

Click here to see the complete history of Ali Tehrani’s form 4 insider trades.

Insider Ownership Summary of Ali Tehrani

Ticker Comapny Transaction Date Type of Owner
ZYME Zymeworks Inc 2021-07-16 director & Chief Executive Officer

Ali Tehrani Latest Holdings Summary

Ali Tehrani currently owns a total of 1 stock. Ali Tehrani owns 315,836 shares of Zymeworks Inc (ZYME) as of July 16, 2021, with a value of $5 Million.

Latest Holdings of Ali Tehrani

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYME Zymeworks Inc 2021-07-16 315,836 16.63 5,252,353

Holding Weightings of Ali Tehrani


Ali Tehrani Form 4 Trading Tracker

According to the SEC Form 4 filings, Ali Tehrani has made a total of 6 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Zymeworks Inc is the sale of 44,991 shares on July 16, 2021, which brought Ali Tehrani around $2 Million.

Insider Trading History of Ali Tehrani

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ali Tehrani Trading Performance

GuruFocus tracks the stock performance after each of Ali Tehrani's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ali Tehrani is 6.86%. GuruFocus also compares Ali Tehrani's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ali Tehrani within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ali Tehrani's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ali Tehrani

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -9.49 LIMIT LIMIT LIMIT LIMIT LIMIT

Ali Tehrani Ownership Network

Ownership Network List of Ali Tehrani

No Data

Ownership Network Relation of Ali Tehrani

Insider Network Chart

Ali Tehrani Owned Company Details

What does Zymeworks Inc do?

Who are the key executives at Zymeworks Inc?

Ali Tehrani is the director & Chief Executive Officer of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and Chief Scientific Officer Paul Andrew Moore .

Zymeworks Inc (ZYME) Insider Trades Summary

Over the past 18 months, Ali Tehrani made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net sale of 6,880 shares made by Christopher Astle , a net purchase of 3,350,000 shares made by Ecor1 Capital, Llc , and a net sale of 23,904 shares made by Kenneth Galbraith .

In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,583 shares of Zymeworks Inc (ZYME) were sold and 3,350,000 shares were bought by its insiders, resulting in a net purchase of 3,309,417 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zymeworks Inc Insider Transactions

No Available Data

Ali Tehrani Mailing Address

Above is the net worth, insider trading, and ownership report for Ali Tehrani. You might contact Ali Tehrani via mailing address: 1385 West 8th Avenue, Suite 540, Vancouver A1 V6h3v9.